Bronchial Blockers vs Double-Lumen Tubes in Obese Patients
Recruiting now · Not applicable
Conditions studied: One-lung Ventilation
In brief
The goal of this clinical trial is to evaluate the efficacy of bronchial blockers and double-lumen tubes in achieving one-lung ventilation in obese patients undergoing lung resections. The primary question it aims to answer is: • Is intraoperative hypoxia significantly different depending on the device used? Researchers will compare the use of bronchial blockers and double-lumen tubes to assess differences in efficacy and safety. Participants will not be required to perform any tasks.
Key facts
- Study ID
- NCT07031986
- Run by
- Paulo Andrés Cano Jiménez
- People needed
- 46
- Starts
- 2024-08-15
- Expected to finish
- 2026-04-01
- Last updated by the study team
- 2025-06-22
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- BMI ≥ 30 kg/m2
- Diagnostic or clinical suspicion of lung cancer
- Lung resection surgery (lobectomy, segmentectomy or wedge resection) by VATS or thoracotomy, requiring one-lung ventilation.
- Use of bronchial blocker or double-lumen tube for one-lung ventilation.
You may not qualify if…
- Patients with evident anatomic alterations, in which double-lumen tubes may be contraindicated.
- Emergency surgeries.
Where it is running
- Hospital Son Espases — Palma de Mallorca, Balearic Islands, Spain (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.